Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITGB3 | P05106 | 20/20 | 0.69 |
| ▸ | ITGAV | P06756 | 20/20 | 0.69 |
| ▸ | ITGA2B | P08514 | 2/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8468526 | 0.88 | ITGB3 (0.77) | ITGB3ITGAVITGA2B | |
| SCHEMBL8465392 | 0.87 | ITGB3 (0.86) | ITGB3ITGAVITGA2B | |
| Trifluoroacetic Acid SCHEMBL7392211 | 0.84 | ITGB3 (0.80) | ITGB3ITGAVITGA2B | |
| SCHEMBL8467626 | 0.83 | ITGB3 (0.62) | ITGB3ITGAVITGA2B | |
| SCHEMBL7074204 | 0.82 | ITGB3 (1.00) | ITGB3ITGAVITGA2B | |
| SCHEMBL7072095 | 0.82 | ITGB3 (1.00) | ITGB3ITGAVITGA2B | |
| SCHEMBL5972772 | 0.81 | ITGB3 (0.74) | ITGB3ITGAVITGA2B | |
| SCHEMBL7077079 | 0.81 | ITGB3 (1.00) | ITGB3ITGAVITGA2B | |
| SCHEMBL6946659 | 0.81 | ITGB3 (1.00) | ITGB3ITGAVITGA2B | |
| SCHEMBL7509393 | 0.79 | ITGB3 (0.85) | ITGB3ITGAVITGA2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0869787-A4 | VITRONECTIN RECEPTOR ANTAGONISTS | SMITHKLINE BEECHAM CORP (US) | 1999-03-24 | — | — | EP | disclosed |
| EP-0869787-A1 | VITRONECTIN RECEPTOR ANTAGONISTS | SMITHKLINE BEECHAM CORPORATION (US) | 1998-10-14 | — | — | EP | disclosed |
| WO-1997024119-A1 | VITRONECTIN RECEPTOR ANTAGONISTS | SMITHKLINE BEECHAM CORPORATION (US) | 1997-07-10 | — | — | WO | disclosed |